Influence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus: A Randomized Cross-Over Trial

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Influence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus : A Randomized Cross-Over Trial. / Kristensen, Peter Lommer; Pedersen-Bjergaard, Ulrik; Kjær, Troels Wesenberg; Olsen, Niels Vidiendal; Dela, Flemming; Holst, Jens Juul; Faber, Jens; Tarnow, Lise; Thorsteinsson, Birger.

In: P L o S One, Vol. 8, No. 4, e59672, 05.04.2013, p. 1-8.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Kristensen, PL, Pedersen-Bjergaard, U, Kjær, TW, Olsen, NV, Dela, F, Holst, JJ, Faber, J, Tarnow, L & Thorsteinsson, B 2013, 'Influence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus: A Randomized Cross-Over Trial', P L o S One, vol. 8, no. 4, e59672, pp. 1-8. https://doi.org/10.1371/journal.pone.0059672

APA

Kristensen, P. L., Pedersen-Bjergaard, U., Kjær, T. W., Olsen, N. V., Dela, F., Holst, J. J., Faber, J., Tarnow, L., & Thorsteinsson, B. (2013). Influence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus: A Randomized Cross-Over Trial. P L o S One, 8(4), 1-8. [e59672]. https://doi.org/10.1371/journal.pone.0059672

Vancouver

Kristensen PL, Pedersen-Bjergaard U, Kjær TW, Olsen NV, Dela F, Holst JJ et al. Influence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus: A Randomized Cross-Over Trial. P L o S One. 2013 Apr 5;8(4):1-8. e59672. https://doi.org/10.1371/journal.pone.0059672

Author

Kristensen, Peter Lommer ; Pedersen-Bjergaard, Ulrik ; Kjær, Troels Wesenberg ; Olsen, Niels Vidiendal ; Dela, Flemming ; Holst, Jens Juul ; Faber, Jens ; Tarnow, Lise ; Thorsteinsson, Birger. / Influence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus : A Randomized Cross-Over Trial. In: P L o S One. 2013 ; Vol. 8, No. 4. pp. 1-8.

Bibtex

@article{63466b752b2d4c8488bba5f22cac9e81,
title = "Influence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus: A Randomized Cross-Over Trial",
abstract = "The incidence of severe hypoglycemia in type 1 diabetes has not decreased over the past decades. New treatment modalities minimizing the risk of hypoglycemic episodes and attenuating hypoglycemic cognitive dysfunction are needed. We studied if treatment with the neuroprotective hormone erythropoietin (EPO) enhances cognitive function during hypoglycemia.",
author = "Kristensen, {Peter Lommer} and Ulrik Pedersen-Bjergaard and Kj{\ae}r, {Troels Wesenberg} and Olsen, {Niels Vidiendal} and Flemming Dela and Holst, {Jens Juul} and Jens Faber and Lise Tarnow and Birger Thorsteinsson",
year = "2013",
month = apr,
day = "5",
doi = "10.1371/journal.pone.0059672",
language = "English",
volume = "8",
pages = "1--8",
journal = "PLoS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "4",

}

RIS

TY - JOUR

T1 - Influence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus

T2 - A Randomized Cross-Over Trial

AU - Kristensen, Peter Lommer

AU - Pedersen-Bjergaard, Ulrik

AU - Kjær, Troels Wesenberg

AU - Olsen, Niels Vidiendal

AU - Dela, Flemming

AU - Holst, Jens Juul

AU - Faber, Jens

AU - Tarnow, Lise

AU - Thorsteinsson, Birger

PY - 2013/4/5

Y1 - 2013/4/5

N2 - The incidence of severe hypoglycemia in type 1 diabetes has not decreased over the past decades. New treatment modalities minimizing the risk of hypoglycemic episodes and attenuating hypoglycemic cognitive dysfunction are needed. We studied if treatment with the neuroprotective hormone erythropoietin (EPO) enhances cognitive function during hypoglycemia.

AB - The incidence of severe hypoglycemia in type 1 diabetes has not decreased over the past decades. New treatment modalities minimizing the risk of hypoglycemic episodes and attenuating hypoglycemic cognitive dysfunction are needed. We studied if treatment with the neuroprotective hormone erythropoietin (EPO) enhances cognitive function during hypoglycemia.

U2 - 10.1371/journal.pone.0059672

DO - 10.1371/journal.pone.0059672

M3 - Journal article

C2 - 23577069

VL - 8

SP - 1

EP - 8

JO - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

IS - 4

M1 - e59672

ER -

ID: 45839942